Berghausen, Joerg
Novartis (Switzerland) · Novartis Institutes for BioMedical Research
2 papers on CoChat
Most cited papers
- Verified
Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors
Holzer, P., Masuya, K., Furet, P., Kallen, J., Valat-Stachyra, T., Ferretti, S., Berghausen, J., Bouisset-Leonard, M., Buschmann, N., Pissot-Soldermann, C., et al. (2015) · Journal of Medicinal Chemistry
Cancer-related Molecular PathwaysCancer Mechanisms and Therapy
Cited by 203
- Verified
Simulated rat intestinal fluid improves oral exposure prediction for poorly soluble compounds over a wide dose range
Berghausen, J., Seiler, F. H., Gobeau, N., & Faller, B. (2016) · ADMET & DMPK
Drug Solubulity and Delivery SystemsPharmacogenetics and Drug Metabolism
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free